This white paper from Abbott examines a cross-section of the global healthcare system leveraging primary research with 1,400+ respondents including patients, physicians, and administrators.
The Covid-19 pandemic has forced healthcare systems and physician’s practices to innovate and try new approaches to care delivery, resulting in the explosive growth of telehealth services. But a comprehensive digital solution can involve much more than the video encounters people typically associate with virtual care.
“If we’ve learned anything this year, it’s that kindness is also contagious.” This is the rallying cry behind Klick Health’s 2020 holiday video ‘When Nobody’s Watching’, which launched on Dec. 8 on YouTube. For each view, Klick will donate $1 to Sesame Workshop, the non-profit media and education organization behind Sesame Street that’s known for its mission to help children grow smarter, stronger, and kinder.
President-elect Joe Biden tapped California Attorney General Xavier Becerra to serve as his first secretary of the Department of Health and Human Services (HHS).
Kate Cronin, Global CEO of Ogilvy Health, shares her views on a variety of healthcare industry topics in a Q&A with PharmaLive.
U.S. hospitals, weighing high demand and tight supplies, said they may limit use of the new Eli Lilly and Co. nantibody drug bamlanivimab to Covid-19 patients with multiple risk factors for serious illness or to those whose immune systems have not begun to fight the infection.
Outcome Health announced the launch of Who Saves Me?, a campaign to bring awareness to the overwhelming percentage of physicians who quietly suffer from burnout and mental health struggles.
A physician who heads the influential U.S. Food and Drug Administration vaccine advisory committee recused herself from the panel’s review of Covid-19 vaccines because of her role overseeing a clinical trial for Moderna Inc.’s candidate, her spokeswoman told Reuters.
The U.S. Food and Drug Administration approved Athena Bioscience LLC’s Qdolo (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
While Humira remains the best-selling prescription product worldwide, Keytruda has risen to the No. 2 global rank and is on track to eventually claim the top spot.